Abstract:Abstract Background Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) infection can lead to a broad spectrum of lung diseases, including infectious diseases and tumors. Recently, with the wide application of bronchoscopes and cytopathology of bronchoalveolar lavage fluid (BALF), the diagnostic efficiency of lung diseases has improved. The present study focuses on analyzing the cytopathologic characteristics of BALF in the diagnosis of HIV/AIDS-related lung disease and comparing the lung disease spectrum between HIV and HIV-uninfected patients. Methods BALF specimens were collected from 2211 patients. Using ThinPrep liquid-based technology, the cytologic smears were prepared by staining with Hematoxylin and Eosin (HE), Gomori's methenamine silver (GMS), and Periodic Acid Schiff (PAS), acid-fast and immunocytochemical (ICC) staining. Real-time PCR was used to detect cytomegalovirus (CMV) and Mycobacterium tuberculosis (M. tuberculosis) in the remaining BALF. PCR-reverse dot hybridization was used for mycobacterial species identification. Results From the 2211 BALF specimens, 1768 (79.96%) were specimens from HIV-infected patients, and 443 (20.04%) were speciments from HIV-uninfected patients. The HIV-infected patients with a median age of 38.5 ± 11.3 years were markedly younger than the HIV-uninfected patients (52.9 ± 14.9 years) ( p < 0.01). We found that 1635 (92.5%) HIV-infected patients were males, showing a prominently higher proportion than those without HIV infection (71.1%) ( p < 0.01). Meanwhile, 1045 specific lesions were found in 1768 HIV-infected patients (59.1%), including 1034 cases of infectious diseases and 11 neoplastic lesions, also exhibiting a distinctly higher proportion compared to the HIV-uninfected patients (12.2%) ( p < 0.001). For the HIV-infected group, a distinctly higher proportion of single infection lesions (724/1768, 41%) was noted than the HIV-uninfected group (14/443, 3.2%) ( p < 0.001). Among single infection lesions, the most common was Cytomegalovirus(CMV) infection (20.9%) for the HIV-infected group, followed by Pneumocystis jiroveci (PJ) (13.0%), Fungal (3.5%), and Mycobacterial infections (3.4%), of which M. tuberculosis infection accounted for 3.1%. Double infections (300/1768, 17.0%) and Triple infections (10/1768, 0.6%) were found only among the patients with HIV. The malignancies among HIV-infected patients included adenocarcinomas (0.22%), small cell carcinomas (0.2%), squamous cell carcinomas (0.1%), and diffuse large B-cell lymphoma (0.1%). HIV-infected patients exhibited a significantly lower incidence of neoplastic lesions (0.6% vs. 9.0%) than the HIV-uninfected patients ( p < 0.001). Conclusions There was a significant difference in the spectrum of lung diseases between HIV-infected and non-infected patients diagnosed by BALF cytopathology.

Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research

Effect and security of bronchoalveolar lavage on infected atelectasis in children

Utility of bronchoscopy in immunocompromised paediatric patients: Systematic review

Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction

Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium

The bronchoalveolar lavage dilution conundrum: an updated view on a long-standing problem

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Pathogenic Microorganism Detection in AIDS Patients Using Bronchoalveolar Lavage Fluid.

Utility of bile acids in large airway bronchial wash versus bronchoalveolar lavage as biomarkers of microaspiration in lung transplant recipients: a retrospective cohort study

Optimization of bronchoalveolar lavage fluid volume for untargeted lipidomic method and application in influenza A virus infection

Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease

Optimized method for higher yield of alveolar macrophage isolation for ex vivo studies

Influencing Factors of Positive Rate of Bronchoalveolar Lavage Fluid in Patients with Pneumonia: a Multicenter Retrospective Study

Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation

Insights from T Cell Profiling in BAL and PBMC

[Application of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation].

Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol

Microbiota and Mycobiota in Bronchoalveolar Lavage Fluid of Silicosis Patients.

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants

Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection